Heart Transplantation Clinical Trial
Official title:
Changes in Blood Measured Before, During and After Exercise in Heart Transplant Recipients. Imminently Effect of Interval Training With High Intensity Compared With Continuous Moderate Intensity
Verified date | November 2016 |
Source | Oslo University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Norway: Data Protection Authority |
Study type | Interventional |
High intensity Interval training (HIT) has repeatedly been documented to have superior positive effects on oxygen uptake and general physical health compared to continuous moderate exercise in healthy individuals and patients with heart disease. Recently, the same effect has been shown in heart transplanted recipients. Which mechanisms that explains this difference is uncertain; the effect can be due to changes in the heart or changes in the peripheral tissue and muscles. To explore these mechanisms the investigators will in this study compare two different exercise modalities, and explore how different biomarkers change in blood, related to exercise.
Status | Completed |
Enrollment | 19 |
Est. completion date | November 2015 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria (HTx): - 1-10 years after heart transplantation - Lives in Oslo or near Oslo - Stable health condition - Optimal medical treatment/ medication - No limiting physical handicap - Written consent Inclusion healthy control: - No verified heart disease - Willing to preform the study - Over 18 years - Written consent Exclusion Criteria: - Under 1 year or over 10 year since HTx. - Lives far from Oslo - Unstable health condition - Not optimal medical treatment and/ or medication - Limiting physical handicap - Under 18 years - Not written consent |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Norway | OUS- Rikshospitalet | Oslo |
Lead Sponsor | Collaborator |
---|---|
Oslo University Hospital | Norwegian Health Association |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in crp with interval training compared to moderate training | 1 week | No | |
Primary | Changes in interleukin levels with interval training compared to moderate training | 1 week | No | |
Primary | Changes in ICAM levels with interval training compared to moderate training | 1 week | No | |
Primary | Changes in MiRNA levels with interval training compared to moderate training | 1 week | No | |
Secondary | Questionnaire of quality of life | baseline | No | |
Secondary | Oxygen uptake | V02 peak measured på exercise test on treadmill. | baseline | No |
Secondary | Questionnaire of physical activity | baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06035991 -
First Clinical Evaluation of Heart Transplantation With Grafts Preserved Using an Ex-vivo Extended Perfusion System
|
N/A | |
Recruiting |
NCT01927614 -
Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy
|
N/A | |
Recruiting |
NCT01705015 -
Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement
|
N/A | |
Completed |
NCT01655563 -
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
|
Phase 2 | |
Completed |
NCT01028599 -
Effect of Physical Training on Oxygen Uptake and Endothelial Function in Heart Transplant Recipients
|
N/A | |
Completed |
NCT00531921 -
Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival
|
N/A | |
Terminated |
NCT00420537 -
Shift to Everolimus (RAD) Kidney Sparing Study
|
Phase 4 | |
Enrolling by invitation |
NCT03292861 -
The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
|
Phase 2 | |
Recruiting |
NCT04924491 -
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT05270902 -
Haemoadsorption During Heart Transplantation
|
N/A | |
Completed |
NCT05289180 -
Brachial Right Ventricle - Endomyocardial Biopsy
|
||
Recruiting |
NCT03687723 -
Observational Study of the Clinical Use of the OCS™ Heart
|
||
Completed |
NCT01091194 -
Effect of Exercise After Heart Transplantation
|
Phase 2 | |
Completed |
NCT01182571 -
Exploration of Fatigue, Uncertainty, Depression and Quality of Life in Heart Transplantation Recipients
|
N/A | |
Terminated |
NCT00678002 -
Quality of Life in Pediatric Transplant Patients
|
||
Withdrawn |
NCT00780637 -
Brachial Artery t-PA Release in Heart Transplant Recipients
|
N/A | |
Withdrawn |
NCT00780377 -
Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
|
N/A | |
Terminated |
NCT00121784 -
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
|
Phase 4 | |
Withdrawn |
NCT00572286 -
Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study
|
N/A | |
Completed |
NCT00123331 -
Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
|
Phase 4 |